NO996573D0 - Spesielle diarylimidazol-derivater, en ny klasse av NPY- spesifikke ligander - Google Patents

Spesielle diarylimidazol-derivater, en ny klasse av NPY- spesifikke ligander

Info

Publication number
NO996573D0
NO996573D0 NO996573A NO996573A NO996573D0 NO 996573 D0 NO996573 D0 NO 996573D0 NO 996573 A NO996573 A NO 996573A NO 996573 A NO996573 A NO 996573A NO 996573 D0 NO996573 D0 NO 996573D0
Authority
NO
Norway
Prior art keywords
npy
special
new class
specific ligands
diarylimidazole derivatives
Prior art date
Application number
NO996573A
Other languages
English (en)
Other versions
NO996573L (no
Inventor
Andrew Thurkauf
Jun Yuan
Alan Hutchison
Charles A Blum
Richard L Elliot
Marlys Hammond
Original Assignee
Neurogen Corp
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp, Pfizer filed Critical Neurogen Corp
Publication of NO996573D0 publication Critical patent/NO996573D0/no
Publication of NO996573L publication Critical patent/NO996573L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO996573A 1997-07-03 1999-12-30 Spesielle diarylimidazol-derivater, en ny klasse av NPY- spesifikke ligander NO996573L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5171197P 1997-07-03 1997-07-03
PCT/US1998/013861 WO1999001128A1 (en) 1997-07-03 1998-07-02 Certain diarylimidazole derivatives; a new class of npy specific ligands

Publications (2)

Publication Number Publication Date
NO996573D0 true NO996573D0 (no) 1999-12-30
NO996573L NO996573L (no) 2000-02-23

Family

ID=21972909

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996573A NO996573L (no) 1997-07-03 1999-12-30 Spesielle diarylimidazol-derivater, en ny klasse av NPY- spesifikke ligander

Country Status (13)

Country Link
US (2) US6121260A (no)
EP (1) EP0996443A1 (no)
JP (1) JP2002515400A (no)
KR (1) KR20010020610A (no)
CN (1) CN1265033A (no)
AU (1) AU744297B2 (no)
BR (1) BR9810651A (no)
CA (1) CA2294898A1 (no)
HU (1) HUP0003934A3 (no)
IL (1) IL133731A0 (no)
NO (1) NO996573L (no)
PL (1) PL337887A1 (no)
WO (1) WO1999001128A1 (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590106B2 (en) * 1997-05-09 2003-07-08 Pharm-Eco Laboratories, Inc. Amino acid derivatives and methods of making the same
US6121260A (en) * 1997-07-03 2000-09-19 Neurogen Corporation Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
DK1183245T3 (da) 1999-04-22 2007-09-24 Lundbeck & Co As H Selektive NPY(Y5)-antagonister
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
AU2935200A (en) 1999-04-30 2000-11-17 Pfizer Products Inc. Compounds for the treatment of obesity
AR024077A1 (es) 1999-05-25 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
CA2380866A1 (en) * 1999-06-30 2001-01-11 Synaptic Pharmaceutical Corporation Selective npy (y5) antagonists
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
EP1070708B1 (en) * 1999-07-21 2004-01-14 F. Hoffmann-La Roche Ag Triazole derivatives
IL149872A0 (en) * 1999-12-16 2002-11-10 Schering Corp Substituted imidazole neuropeptide y y5 receptor antagonists
US7064142B2 (en) 2000-02-22 2006-06-20 Banyu Pharmaceutical, Co., Ltd. Imidazonline compounds
CN100540538C (zh) 2001-04-16 2009-09-16 田边三菱制药株式会社 高传导率钙-活化k通道开启剂
CA2449544A1 (en) * 2001-06-08 2002-12-19 Cytovia, Inc. Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
US7124183B2 (en) 2001-09-26 2006-10-17 Bell Security Solutions Inc. Method and apparatus for secure distributed managed network information services with redundancy
AU2003224335A1 (en) * 2002-05-15 2003-12-02 Smithkline Beecham Corporation Benzoxazine and benzoxazinone substituted triazoles
BRPI0313763B8 (pt) 2002-08-19 2021-05-25 4325231 Canada Inc imidazóis 2,4,5-trissubstituídos, seus usos, e composições farmacêutica e anti-microbiana
US6958347B2 (en) 2002-12-18 2005-10-25 Pfizer Inc. Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists
AU2003303373B8 (en) * 2002-12-18 2010-06-10 Cytovia, Inc. 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
US6949564B2 (en) * 2002-12-18 2005-09-27 Pfizer Inc. NPY-5 antagonists
DK1692113T3 (en) 2003-11-14 2018-01-08 Lorus Therapeutics Inc ARYLIMIDAZOLES AND USE THEREOF AS ANTICANCES
KR101074640B1 (ko) * 2004-06-10 2011-10-19 시코쿠가세이고교가부시키가이샤 납땜 동안 구리 표면에 사용하기 위한 페닐나프틸이미다졸
JP4694251B2 (ja) * 2004-06-10 2011-06-08 四国化成工業株式会社 無鉛半田付け用の銅または銅合金の表面処理剤及びその利用
CN101624374B (zh) * 2004-06-10 2012-03-21 四国化成工业株式会社 在焊接过程中用于铜表面上的苯基萘基咪唑
CN101248072B (zh) 2005-05-25 2013-01-23 劳洛斯治疗公司 2-吲哚基咪唑并[4,5-d]菲咯啉衍生物及其在癌症治疗中的用途
TW200804345A (en) * 2005-08-30 2008-01-16 Novartis Ag Substituted benzimidazoles and methods of preparation
US9447049B2 (en) * 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
DK2303021T3 (en) 2008-06-16 2019-04-08 Univ Tennessee Res Found RELATIONSHIPS FOR TREATING CANCER
JP5361316B2 (ja) * 2008-10-02 2013-12-04 株式会社タムラ製作所 表面処理剤、プリント回路基板およびその製造方法
JP5615227B2 (ja) * 2011-05-23 2014-10-29 四国化成工業株式会社 銅または銅合金の表面処理剤及びその利用
JP5858884B2 (ja) * 2012-08-16 2016-02-10 四国化成工業株式会社 チオフェン環を有するイミダゾール化合物
JP5892605B2 (ja) * 2012-08-17 2016-03-23 四国化成工業株式会社 4−(2−チエニル)イミダゾール化合物
WO2014153464A2 (en) 2013-03-20 2014-09-25 Lorus Therapeutics Inc. 2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
CN105764511B (zh) 2013-10-04 2019-01-11 艾普托斯生物科学公司 用于治疗癌症的组合物和方法
RU2733393C9 (ru) 2014-05-06 2021-09-09 Джи Ти Икс, ИНК. Соединения для лечения рака
CN104974095B (zh) * 2015-06-30 2017-09-15 浙江大学 2,4,5‑多取代咪唑类化合物及制备方法
CN111417395A (zh) 2017-10-30 2020-07-14 艾普托斯生物科学公司 用于治疗癌症的芳基咪唑
WO2022236253A1 (en) * 2021-05-03 2022-11-10 Nuvation Bio Inc. Heterocyclic compounds as kinase inhibitors
EP4173485A1 (en) * 2021-10-27 2023-05-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Protein aggregation inhibiting compounds for plant disease control
CN115043779B (zh) * 2022-06-14 2024-06-25 广东金柏化学有限公司 一种2,4-二苯基咪唑化合物及其制备方法与应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE297816C (no) *
US3297710A (en) * 1963-04-09 1967-01-10 Du Pont Oxoarylidene-imidazoles
US3657441A (en) * 1970-07-30 1972-04-18 Merck & Co Inc Method of inhibiting the formation of phenylethanolamine n-methyl transferase with imidazoles
US3707475A (en) 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
US4853383A (en) * 1975-03-03 1989-08-01 Merck & Co., Inc. β-blocking substituted imidazoles
US4134983A (en) * 1975-03-03 1979-01-16 Merck & Co., Inc. 3-amino-2-or-propoxyaryl substituted imidazoles
SU1051076A1 (ru) * 1982-04-09 1983-10-30 Алтайский политехнический институт Способ получени производных имидазола
IT1206498B (it) 1983-07-18 1989-04-27 Angeli Inst Spa Derivati amidinici del4-fenilmidazolo 2-sostituto processi per la loro preparazione e loro uso farmaceutico.
DE3411997A1 (de) * 1984-03-31 1985-10-17 Boehringer Mannheim Gmbh, 6800 Mannheim Neue redox-indikatoren
IN165525B (no) * 1984-07-23 1989-11-04 Shinetsu Chemical Co
PT80975B (pt) * 1984-08-17 1987-11-11 Shinetsu Chemical Co Processo para a preparacao de um polimero de vinilo
IL83467A0 (en) * 1986-08-15 1988-01-31 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same
JP2630432B2 (ja) * 1987-08-24 1997-07-16 コニカ株式会社 新規なシアンカプラーを含有するハロゲン化銀カラー写真感光材料
JP2700475B2 (ja) * 1988-07-30 1998-01-21 コニカ株式会社 非線形光学材料および非線形光学素子
DE3835195A1 (de) * 1988-10-15 1990-04-19 Basf Ag Verfahren zur herstellung von p-nitrophenyl-imidazolen
AU621245B2 (en) * 1989-10-17 1992-03-05 Boehringer Mannheim Gmbh Hydrolase substrates, a process for the preparation thereof and agents containing them
DE59006842D1 (de) * 1990-03-30 1994-09-22 Heumann Pharma Gmbh & Co Verwendung von Guanidinderivaten zur Herstellung eines Arzneimittels mit NPY-antagonistischer Wirkung.
US5296609A (en) * 1993-04-09 1994-03-22 Syntex Pharmaceuticals, Ltd. Process for the preparation of 1,2,4-substituted imidazoles and related aminoalkylimidazole derivatives
TW270944B (no) * 1993-05-10 1996-02-21 Shikoku Kakoki Co Ltd
US5620999A (en) * 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
WO1997020823A2 (en) * 1995-12-01 1997-06-12 Novartis Ag 2-amino quinazoline derivatives as npy receptor antagonists
US6121260A (en) * 1997-07-03 2000-09-19 Neurogen Corporation Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives

Also Published As

Publication number Publication date
US6515133B1 (en) 2003-02-04
US6121260A (en) 2000-09-19
HUP0003934A2 (hu) 2001-11-28
HUP0003934A3 (en) 2002-01-28
AU744297B2 (en) 2002-02-21
JP2002515400A (ja) 2002-05-28
AU8286898A (en) 1999-01-25
NO996573L (no) 2000-02-23
BR9810651A (pt) 2000-10-03
PL337887A1 (en) 2000-09-11
EP0996443A1 (en) 2000-05-03
CN1265033A (zh) 2000-08-30
CA2294898A1 (en) 1999-01-14
KR20010020610A (ko) 2001-03-15
WO1999001128A1 (en) 1999-01-14
IL133731A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
NO972091D0 (no) Bestemte substituerte benzylaminderivater; en ny klasse nouropeptid-yl-spesifikke ligander
IL133731A0 (en) Certain diarylimidazole derivatives, a new class of npy specific ligands
DE69907964D1 (de) 1,2-annelierte chinolinderivate
NO971423D0 (no) Bestemte aminometyl-fenylimidazol-derivater; en ny klasse spesifikke dopaminreseptor-undertype-ligander
DK0966477T3 (da) 3'-N-oxid, 3'-N-dimethylamin, 9-oxim-erythromycin A-derivater
IS1998B (is) 4'' -setnar - 9 - deoxó - 9 - aza - 9a - hómóerýþrómýsín A afleiður
CY2007024I2 (el) Kαινοφανη παραγωγα 3.3-διαφαινυλοπροπυλινων
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
DK0918761T3 (da) Visse amido- og aminosubstituerede benzylaminderivater, en ny klasse af neuropeptid Y1-specifikke ligander
DE69715847D1 (de) Halogensubstituierte Carbamatderivate von 2-Phenyl-1,2-ethandiol
DK0864582T3 (da) Hypolidemiske 1,4-benzothiazepin-1,1-dioxider
FI974139A0 (fi) Foerfarande foer modifiering av cellulosa
DE69932408D1 (de) Radiale strömungsmaschine
FI952424L (fi) 11,21-bisfenyyli-19-norpregaanijohdannaisia
DE69800225D1 (de) Kapselmaschine
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
FR2730007B1 (fr) Machine a ecoulement radial
EE9900391A (et) Uus protsess
ITBO970535A0 (it) Macchina impacchettatrice.
FI973644L (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
NO995005L (no) En ny fremgangsmåte
FI955933A7 (fi) Abeo-ergoliinijohdannaiset 5HT1A-ligandeina
NO319779B1 (no) Arbeidsantrekk, saerlig skogsarbeiderantrekk, bestaende av en bukse og av en jakke.
FI972885A0 (fi) Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application